ASTEGIANO, MARCO
ASTEGIANO, MARCO
SCIENZE MEDICHE
Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease
2008-01-01 Simondi D.; Mengozzi G.; Betteto S.; Bonardi R.; Ghignone R.P.; Fagoonee S.; Pellicano R.; Sguazzini C.; Pagni R.; Rizzetto M.; Astegiano M.
Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn's disease: the extrapolation concept
2021-01-01 Ribaldone, Davide Giuseppe; Vernero, Marta; Astegiano, Marco
Efficacy of a preparation based on calcium butyrate, bifidobacterium bifidum, bifidobacterium lactis, and fructooligosaccharides in the prevention of relapse in ulcerative colitis: A prospective observational study
2021-01-01 Caviglia G.P.; De Blasio F.; Vernero M.; Armandi A.; Rosso C.; Saracco G.M.; Bugianesi E.; Astegiano M.; Ribaldone D.G.
Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy
2023-01-01 Caviglia, Gian Paolo; Garrone, Angela; Bertolino, Chiara; Vanni, Riccardo; Bretto, Elisabetta; Poshnjari, Anxhela; Tribocco, Elisa; Frara, Simone; Armandi, Angelo; Astegiano, Marco; Saracco, Giorgio Maria; Bertolusso, Luciano; Ribaldone, Davide Giuseppe
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk
2023-01-01 Francavilla, Antonio; Ferrero, Giulio; Pardini, Barbara; Tarallo, Sonia; Zanatto, Laura; Caviglia, Gian Paolo; Sieri, Sabina; Grioni, Sara; Francescato, Giulia; Stalla, Francesco; Guiotto, Cristina; Crocella, Lucia; Astegiano, Marco; Bruno, Mauro; Calvo, Pier Luigi; Vineis, Paolo; Ribaldone, Davide Giuseppe; Naccarati, Alessio
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study
2021-01-01 Ribaldone D.G.; Imperatore N.; Le Grazie M.; Furfaro F.; Balestrieri P.; De Blasio F.; Fagoonee S.; Mosso E.; Boano V.; Reggio D.; Sarli E.; Castiglione F.; Milla M.; Vecchi M.; Saracco G.M.; Salizzoni M.; Romagnoli R.; Fiorino G.; Astegiano M.
Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis
2021-01-01 Ditto, Maria Chiara; Parisi, Simone; Landolfi, Gianpiero; Borrelli, Richard; Realmuto, Cristina; Finucci, Annacarla; Caviglia, Gian Paolo; Ribaldone, Davide Giuseppe; Astegiano, Marco; Zanetti, Anna; Carrara, Greta; Scirè, Carlo Alberto; Antivalle, Marco; Sarzi-Puttini, Piercarlo; Fusaro, Enrico
Late is too late? Surgical timing and postoperative complications after primary ileocolic resection for Crohn’s disease
2022-01-01 Lavorini E, Allaix ME, Ammirati CA, Astegiano M, Morino M, Resegotti A
Predictive Factors of Surgical Recurrence in Patients with Crohn's Disease on Long-Term Follow-Up: A Focus on Histology
2022-01-01 Caviglia, Gian Paolo; Mineo, Chiara Angela; Rosso, Chiara; Armandi, Angelo; Astegiano, Marco; Canavese, Gabriella; Resegotti, Andrea; Saracco, Giorgio Maria; Ribaldone, Davide Giuseppe
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study
2023-01-01 Bergamaschi, G; Castiglione, F; D'Inca, R; Astegiano, M; Fries, W; Milla, M; Ciacci, C; Rizzello, F; Saibeni, S; Ciccocioppo, R; Orlando, A; Bossa, F; Principi, M; Vernia, P; Ricci, C; Scribano, ML; Bodini, G; Mazzucco, D; Bassotti, G; Riegler, G; Buda, A; Neri, M; Caprioli, F; Monica, F; Manca, A; Villa, E; Fiorino, G; Comberlato, M; Aronico, N; Della Corte, C; Caccaro, R; Gionchetti, P; Giuffrida, P; Iovino, P; Lenti, MV; Mengoli, C; Pellegrini, L; Pieraccini, A; Ribaldone, D; Testa, A; Ubezio, C; Viola, A; Vecchi, M; Klersy, C; Di Sabatino, A
RELATIONSHIP BETWEEN ADALIMUMAB, PHARMACOKINETICS AND VITAMIN D-RELATED MARKERS
2020-01-01 Mangia, M; Cusato, J; Ribaldone, DG; Astegiano, M; Saracco, GM; D'Avolio, A
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease
2021-01-01 Caviglia, Gian Paolo; Martini, Giorgio; Armandi, Angelo; Rosso, Chiara; Vernero, Marta; Bugianesi, Elisabetta; Astegiano, Marco; Saracco, Giorgio Maria; Ribaldone, Davide Giuseppe
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study
2021-01-01 Ribaldone, Davide Giuseppe; Tribocco, Elisa; Rosso, Chiara; Armandi, Angelo; Vernero, Marta; Bugianesi, Elisabetta; Astegiano, Marco; Saracco, Giorgio Maria; Caviglia, Gian Paolo
The recipe for the perfect inflammatory bowel disease nurse in a northern Italy tertiary IBD center: going beyond clinical care
2022-01-01 Vernero, Marta; Ribaldone, Davide G; Astegiano, Marco; Pellicano, Rinaldo
Vitamin d-related genetics as predictive biomarker of clinical remission in adalimumab-treated patients affected by crohn’s disease: A pilot study
2021-01-01 Cusato J.; Bertani L.; Antonucci M.; Tomasello C.; Caviglia G.P.; Dibitetto S.; Massano A.; Mangia M.; Mula J.; Ceccarelli L.; Costa F.; Zanzi F.; Astegiano M.; Ribaldone D.G.; D'avolio A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease | 2008 | Simondi D.; Mengozzi G.; Betteto S.; Bonardi R.; Ghignone R.P.; Fagoonee S.; Pellicano R.; Sguazzini C.; Pagni R.; Rizzetto M.; Astegiano M. | |
| Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn's disease: the extrapolation concept | 2021 | Ribaldone, Davide Giuseppe; Vernero, Marta; Astegiano, Marco | |
| Efficacy of a preparation based on calcium butyrate, bifidobacterium bifidum, bifidobacterium lactis, and fructooligosaccharides in the prevention of relapse in ulcerative colitis: A prospective observational study | 2021 | Caviglia G.P.; De Blasio F.; Vernero M.; Armandi A.; Rosso C.; Saracco G.M.; Bugianesi E.; Astegiano M.; Ribaldone D.G. | |
| Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy | 2023 | Caviglia, Gian Paolo; Garrone, Angela; Bertolino, Chiara; Vanni, Riccardo; Bretto, Elisabetta; Poshnjari, Anxhela; Tribocco, Elisa; Frara, Simone; Armandi, Angelo; Astegiano, Marco; Saracco, Giorgio Maria; Bertolusso, Luciano; Ribaldone, Davide Giuseppe | |
| Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk | 2023 | Francavilla, Antonio; Ferrero, Giulio; Pardini, Barbara; Tarallo, Sonia; Zanatto, Laura; Caviglia, Gian Paolo; Sieri, Sabina; Grioni, Sara; Francescato, Giulia; Stalla, Francesco; Guiotto, Cristina; Crocella, Lucia; Astegiano, Marco; Bruno, Mauro; Calvo, Pier Luigi; Vineis, Paolo; Ribaldone, Davide Giuseppe; Naccarati, Alessio | |
| Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study | 2021 | Ribaldone D.G.; Imperatore N.; Le Grazie M.; Furfaro F.; Balestrieri P.; De Blasio F.; Fagoonee S.; Mosso E.; Boano V.; Reggio D.; Sarli E.; Castiglione F.; Milla M.; Vecchi M.; Saracco G.M.; Salizzoni M.; Romagnoli R.; Fiorino G.; Astegiano M. | |
| Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis | 2021 | Ditto, Maria Chiara; Parisi, Simone; Landolfi, Gianpiero; Borrelli, Richard; Realmuto, Cristina; Finucci, Annacarla; Caviglia, Gian Paolo; Ribaldone, Davide Giuseppe; Astegiano, Marco; Zanetti, Anna; Carrara, Greta; Scirè, Carlo Alberto; Antivalle, Marco; Sarzi-Puttini, Piercarlo; Fusaro, Enrico | |
| Late is too late? Surgical timing and postoperative complications after primary ileocolic resection for Crohn’s disease | 2022 | Lavorini E, Allaix ME, Ammirati CA, Astegiano M, Morino M, Resegotti A | |
| Predictive Factors of Surgical Recurrence in Patients with Crohn's Disease on Long-Term Follow-Up: A Focus on Histology | 2022 | Caviglia, Gian Paolo; Mineo, Chiara Angela; Rosso, Chiara; Armandi, Angelo; Astegiano, Marco; Canavese, Gabriella; Resegotti, Andrea; Saracco, Giorgio Maria; Ribaldone, Davide Giuseppe | |
| Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study | 2023 | Bergamaschi, G; Castiglione, F; D'Inca, R; Astegiano, M; Fries, W; Milla, M; Ciacci, C; Rizzello, F; Saibeni, S; Ciccocioppo, R; Orlando, A; Bossa, F; Principi, M; Vernia, P; Ricci, C; Scribano, ML; Bodini, G; Mazzucco, D; Bassotti, G; Riegler, G; Buda, A; Neri, M; Caprioli, F; Monica, F; Manca, A; Villa, E; Fiorino, G; Comberlato, M; Aronico, N; Della Corte, C; Caccaro, R; Gionchetti, P; Giuffrida, P; Iovino, P; Lenti, MV; Mengoli, C; Pellegrini, L; Pieraccini, A; Ribaldone, D; Testa, A; Ubezio, C; Viola, A; Vecchi, M; Klersy, C; Di Sabatino, A | |
| RELATIONSHIP BETWEEN ADALIMUMAB, PHARMACOKINETICS AND VITAMIN D-RELATED MARKERS | 2020 | Mangia, M; Cusato, J; Ribaldone, DG; Astegiano, M; Saracco, GM; D'Avolio, A | |
| Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease | 2021 | Caviglia, Gian Paolo; Martini, Giorgio; Armandi, Angelo; Rosso, Chiara; Vernero, Marta; Bugianesi, Elisabetta; Astegiano, Marco; Saracco, Giorgio Maria; Ribaldone, Davide Giuseppe | |
| Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study | 2021 | Ribaldone, Davide Giuseppe; Tribocco, Elisa; Rosso, Chiara; Armandi, Angelo; Vernero, Marta; Bugianesi, Elisabetta; Astegiano, Marco; Saracco, Giorgio Maria; Caviglia, Gian Paolo | |
| The recipe for the perfect inflammatory bowel disease nurse in a northern Italy tertiary IBD center: going beyond clinical care | 2022 | Vernero, Marta; Ribaldone, Davide G; Astegiano, Marco; Pellicano, Rinaldo | |
| Vitamin d-related genetics as predictive biomarker of clinical remission in adalimumab-treated patients affected by crohn’s disease: A pilot study | 2021 | Cusato J.; Bertani L.; Antonucci M.; Tomasello C.; Caviglia G.P.; Dibitetto S.; Massano A.; Mangia M.; Mula J.; Ceccarelli L.; Costa F.; Zanzi F.; Astegiano M.; Ribaldone D.G.; D'avolio A. |